Search Results - "Vasakova, Ma"

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis by Guenther, Andreas, Krauss, Ekaterina, Tello, Silke, Wagner, Jasmin, Paul, Bettina, Kuhn, Stefan, Maurer, Olga, Heinemann, Sabine, Costabel, Ulrich, Barbero, María Asunción Nieto, Müller, Veronika, Bonniaud, Philippe, Vancheri, Carlo, Wells, Athol, Vasakova, Martina, Pesci, Alberto, Sofia, Matteo, Klepetko, Walter, Seeger, Werner, Drakopanagiotakis, Fotios, Crestani, Bruno

“…Since 2009, IPF patients across Europe are recruited into the eurIPFreg, providing epidemiological data and biomaterials for translational research. The…”
Get full text

Comorbidities and survival in patients with chronic hypersensitivity pneumonitis by Wälscher, Julia, Gross, Benjamin, Morisset, Julie, Johannson, Kerri A, Vasakova, Martina, Bruhwyler, Jacques, Kreuter, Michael

“…Chronic Hypersensitivity Pneumonitis (cHP) is a fibrotic interstitial lung disease (ILD) resulting from repeated exposure to an offending antigen…”
Get full text

Biodegradable polydioxanone stents in the treatment of adult patients with tracheal narrowing by Stehlik, Ludek, Hytych, Vladislav, Letackova, Jana, Kubena, Petr, Vasakova, Martina

“…Biodegradable stents that disintegrate after a period of time are expected to be well tolerated and have advantages over other stents that are more commonly…”
Get full text

Biodegradable tracheal stents: our ten-year experience with adult patients by Stehlik, Ludek, Guha, Debarya, Anandakumar, Sheetal, Taskova, Alice, Vasakova, Martina Koziar

“…Biodegradable (BD) stents made from polydioxanone have been used only in human airways. These stents combine the advantages of classical tracheal stents, and…”
Get full text

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 : an open-label extension study by Raghu, Ganesh, Hamblin, Mark J, Brown, A. Whitney, Golden, Jeffrey A, Ho, Lawrence A, Wijsenbeek, Marlies S, Vasakova, Ma, Pesci, Alberto, Antin-Ozerkis, Danielle E, Meyer, Keith C, Kreuter, Michael, Burgess, Tracy, Kamath, Nikhil, Donaldson, Francis, Richeldi, Luca

“…Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk…”
Get full text

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis by Witt, Sabine, Krauss, Ekaterina, Barbero, María Asunción Nieto, Müller, Veronika, Bonniaud, Philippe, Vancheri, Carlo, Wells, Athol U, Vasakova, Martina, Pesci, Alberto, Klepetko, Walter, Seeger, Werner, Crestani, Bruno, Leidl, Reiner, Holle, Rolf, Schwarzkopf, Larissa, Guenther, Andreas

“…Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of 3-5 years after diagnosis with limited treatment options. The aim of this study…”
Get full text

Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment by Sterclova, Martina, Kishore, Amit, Sikorova, Katerina, Skibova, Jelena, Petrek, Martin, Vasakova, Martina

“…A genetic predisposition has been identified in 30% of idiopathic pulmonary fibrosis (IPF) cases. Although it is highly probable that the genotype affects the…”
Get full text

Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients by Sterclova, Martina, Smetakova, Magdalena, Stehlik, Ludek, Skibova, Jelena, Vasakova, Martina

“…Extrinsic allergic alveolitis (EAA) patients form heterogenous group with different clinical manifestation and different prognosis. We aimed to determine how…”
Get full text

Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood by Svobodova, Tamara, Mejstrikova, Ester, Salzer, Ulrich, Sukova, Martina, Hubacek, Petr, Matej, Radoslav, Vasakova, Martina, Hornofova, Ludmila, Dvorakova, Marcela, Fronkova, Eva, Votava, Felix, Freiberger, Tomas, Pohunek, Petr, Stary, Jan, Janda, Ales

“…GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly…”
Get full text

PAR-2, IL-4R, TGF-β and TNF-α in bronchoalveolar lavage distinguishes extrinsic allergic alveolitis from sarcoidosis by MATĚJ, RADOSLAV, SMĚTÁKOVÁ, MAGDALENA, VAŠÁKOVÁ, MARTINA, NOVÁKOVÁ, JANA, ŠTERCLOVÁ, MARTINA, KUKAL, JAROMÍR, OLEJÁR, TOMÁŠ

“…Sarcoidosis (SARC) and extrinsic allergic alveolitis (EAA) share certain markers, making a differential diagnosis difficult even with histopathological…”
Get full text

R ole of interleukin 4 and its receptor in clinical presentation of chronic extrinsic allergic alveolitis: a pilot study by Sterclova, Martina, Matej, Radoslav, Mandakova, Petra, Skibova, Jelena, Vasakova, Martina

“…Background Th-2 cytokine milieu including interleukin 4 (IL-4) was detected in fibrotic lung diseases. Chronic extrinsic allergic alveolitis (EAA) may be also…”
Get full text

Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone by Májek, Ondrej, Gregor, Jakub, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Sterclová, Martina, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R, Tekavec-Trkanjec, Jasna, Jovanovic, Dragana, Studnicka, Michael, Stoeva, Natalia, Kirchgässler, Klaus-Uwe, Littnerová, Simona, Dusek, Ladislav, Vasáková, Martina Koziar

“…Background There is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis…”
Get full text

Disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic in March-October 2020: An exploratory analysis by Modrák, Martin, Bürkner, Paul-Christian, Sieger, Tomáš, Slisz, Tomáš, Vašáková, Martina, Mesežnikov, Grigorij, Casas-Mendez, Luis Fernando, Vajter, Jaromír, Táborský, Jan, Kubricht, Viktor, Suk, Daniel, Horejsek, Jan, Jedlička, Martin, Mifková, Adriana, Jaroš, Adam, Kubiska, Miroslav, Váchalová, Jana, Šín, Robin, Veverková, Markéta, Pospíšil, Zbyšek, Vohryzková, Julie, Pokrievková, Rebeka, Hrušák, Kristián, Christozova, Kristína, Leos-Barajas, Vianey, Fišer, Karel, Hyánek, Tomáš

“…We collected a multi-centric retrospective dataset of patients (N = 213) who were admitted to ten hospitals in Czech Republic and tested positive for…”
Get full text